文献速递泌尿生殖妇产影像技术与安全CT

基于CT的机器学习影像组学建模:卵巢癌患者的生存预测与机制探索

CT-based Machine Learning Radiomics Modeling: Survival Prediction and Mechanism Exploration in Ovarian Cancer Patients.
PubMed 文献 · Acad Radiol · 2025-01-17

回顾性分析455例卵巢癌患者的CT影像与临床数据,构建基于FIGO分期、肿瘤残留病灶和Rad-score的预后模型。模型在训练组、验证组和测试组中预测1、3、5年总生存的AUC分别为0.816/0.865/0.862、0.845/0.877/0.869和0.899/0.906/0.869。TCGA数据分析提示EMP1为影像组学建模的核心基因,其生物学功能可能与细胞外基质组织和黏着斑相关。

要点

  • 基于FIGO分期、肿瘤残留病灶和Rad-score的临床-影像组学模型可预测卵巢癌患者总生存。
  • 模型在训练组、验证组和测试组的1、3、5年AUC分别为0.816/0.865/0.862、0.845/0.877/0.869和0.899/0.906/0.869。
  • 决策曲线分析和临床影响曲线显示临床-影像组学模型具有较高的净获益和临床适用性。

核心结论

  • 基于FIGO分期、肿瘤残留病灶和Rad-score的预后模型可有效预测卵巢癌患者的总生存。
  • Rad-score可能通过揭示EMP1的表达水平及其生物学功能实现对卵巢癌患者的预后预测。

研究设计与样本

  • 回顾性分析455例卵巢癌患者的影像和临床数据,分为训练队列、验证队列和测试队列。
  • 采用Cox回归分析和LASSO方法筛选特征并构建Rad-score。
  • 开发并评估影像组学模型的预测效能和临床增量价值。
  • 应用癌症基因组图谱(TCGA)的基因组数据揭示不同Rad-score组间的差异基因,通过生物信息学分析和机器学习筛选核心基因并探索其功能。

诊断标准与关键数值

  • 基于FIGO分期、肿瘤残留病灶和Rad-score构建预后模型。
  • ROC曲线显示模型预测1、3、5年生存的AUC在训练组分别为0.816、0.865和0.862。
  • 验证组1、3、5年AUC分别为0.845、0.877和0.869。
  • 测试组1、3、5年AUC分别为0.899、0.906和0.869。
  • 校准曲线显示观测值与预测值具有良好一致性。

临床应用与阅片要点

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

RATIONALE AND OBJECTIVES: To create a radiomics model based on computed tomography (CT) to predict overall survival in ovarian cancer patients. To combine Rad-score with genomic data to explore the association between gene expression and Rad-score.

MATERIALS AND METHODS: Imaging and clinical data from 455 patients with ovarian cancer were retrospectively analyzed. Patients were categorized into training cohort, validation cohort and test cohort. Cox regression analysis and the least absolute shrinkage and selection operator (LASSO) methods were utilized to identify characteristics and develop the Rad-score. Radiomics models were developed and evaluated for predictive efficacy and clinical incremental value. Application of genomic data from the cancer genome atlas (TCGA) to reveal differential genes in different Rad-score groups. Screening hub genes and exploring the functions of hub genes through bioinformatics analysis and machine learning.

RESULTS: Prognostic models based on FIGO, tumor residual disease and Rad-score were developed. The receiver operating characteristic (ROC) curves showed that the 1, 3, and 5 year area under curves (AUCs) of the model were in the training group (0.816, 0.865 and 0.862, respectively), validation group (0.845, 0.877, 0.869, respectively) and test group (0.899, 0.906 and 0.869, respectively) had good predictive accuracy. Calibration curves showed good agreement between observations and predictions. Decision curve analysis revealed a high net benefit of the clinical-radiomics model. The clinical impact curve (CIC) showed good clinical applicability of the clinical-radiomics model. Analysis of sequencing data from the TCGA database revealed EMP1 as a hub gene for radiomics modeling. It revealed that its biological function may be associated with extracellular matrix organization and focal adhesion.

CONCLUSION: Prognostic models based on FIGO, Tumor residual disease, and Rad-score can effectively predict the overall survival (OS) of ovarian cancer patients. Rad-score may enable prognostic prediction of ovarian cancer patients by revealing the expression level of EMP1 and its biological function.

来源:Acad Radiol,查看原文。版权归原作者所有。

引用

  1. Su R, Zhang Y, Li X, et al. CT-based Machine Learning Radiomics Modeling: Survival Prediction and Mechanism Exploration in Ovarian Cancer Patients. Acad Radiol. 2025. PMID: 39827000. doi:10.1016/j.acra.2024.12.047

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。